Leerink Partnrs Issues Optimistic Outlook for TRVI Earnings
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for shares of Trevi Therapeutics in a note issued to investors on Wednesday, June 11th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will post earnings of ($0.08) per share for […]
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for shares of Trevi Therapeutics in a note issued to investors on Wednesday, June 11th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will post earnings of ($0.08) per share for […]
